CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Reber Genetics Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Reber Genetics Co Ltd
3F, No. 25-1
Sec. 4, Ren Ai Road
Phone: +886 227932899p:+886 227932899 TAIPEI, 114  Taiwan Fax: +886 227936799f:+886 227936799
Business Summary
Reber Genetics Co Ltd is a Taiwan-based company principally engaged in the research, development, production and sales of animal vaccines. The Company's main products include PRRSFREETM, a genetically modified subunit vaccine for reproductive and respiratory syndrome in wide pigs; CIRCOFREE, a genetically modified subunit vaccine for porcine circovirus (PCV) infection, and PCCOM, a genetically modified subunit mixed vaccine for PCV infection and reproductive and respiratory syndrome in Shuangbao pigs. The Company distributes its products in domestic market and to overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202312/31/2022Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager HuibangJiang 10/25/2019 10/17/2019
Chief Financial Officer, Head of Finance & Accounting JierenJiang 12/28/2021
Chief Operating Officer ShelleyChiou 11/26/2014 11/26/2014
7 additional Officers and Directors records available in full report.

General Information
Number of Employees: 85 (As of 12/31/2013)
Outstanding Shares: 39,800,000 (As of 6/30/2023)
Shareholders: 792
Stock Exchange: TPO
Fax Number: +886 227936799


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 27, 2024